
STS NATIONAL CARDIAC SURGERY DATABASE
1996 AORTIC VALVE REPLACEMENT + MITRAL VALVE REPLACEMENT PATIENTS
UNIVARIATE ANALYSIS: PRE OPERATIVE RISK VARIABLES
PATIENT POPULATION: 1,005
RISK VARIABLE | Count | % of Pop. | Mortality w/ Variable Present |
| Mortality w/ Variable Absent |
| Relative Risk | c 2 p-Value |
CCS Class II vs. I | 74 | 7.36% | 5/ 74 | 6.76% | 11/ 179 | 6.15% | 1.16 | 0.8560 |
CCS Class III vs. I | 224 | 22.29% | 14/ 224 | 6.25% | 11/ 179 | 6.15% | 1.02 | 0.9650 |
CCS Class IV vs. I | 118 | 11.74% | 21/ 118 | 17.80% | 11/ 179 | 6.15% | 2.89 | 0.0015 |
NYHA Class II vs. I | 104 | 10.35% | 2/ 104 | 1.92% | 6/ 36 | 16.67% | 0.12 | 0.0010 |
NYHA Class III vs. I | 399 | 39.70% | 26/ 399 | 6.52% | 6/ 36 | 16.67% | 0.39 | 0.0250 |
NYHA Class IV vs. I | 234 | 23.28% | 28/ 234 | 11.97% | 6/ 36 | 16.67% | 0.72 | 0.4290 |
Aortic Valve Disease | 874 | 86.97% | 72/ 874 | 8.24% | 14/ 131 | 10.69% | 0.77 | 0.3501 |
Mitral Valve Disease | 871 | 86.67% | 73/ 871 | 8.38% | 13/ 134 | 9.70% | 0.86 | 0.6110 |
Tricuspid Valve Disease | 75 | 7.46% | 9/ 75 | 12.00% | 77/ 930 | 8.28% | 1.45 | 0.2679 |
Pulmonic Valve Disease | 6 | 0.60% | 0/ 6 | 0.00% | 86/ 999 | 8.61% | 0.00 | 0.4523 |
Reoperation #1 vs. First Op | 201 | 20.00% | 19/ 201 | 9.45% | 61/ 761 | 8.02% | 1.18 | 0.5117 |
Multiple Reoperations vs. First Op | 43 | 4.28% | 6/ 43 | 13.95% | 61/ 761 | 8.02% | 1.74 | 0.1705 |
Urgent vs. Elective | 192 | 19.10% | 14/ 192 | 7.29% | 61/ 780 | 7.82% | 0.93 | 0.8057 |
Emergent vs. Elective | 26 | 2.59% | 5/ 26 | 19.23% | 61/ 780 | 7.82% | 2.46 | 0.0369 |
Emergent/Salvage vs. Elective | 7 | 0.70% | 6/ 7 | 85.71% | 61/ 780 | 7.82% | 10.96 | 0.0000 |
Double Vessel Disease vs. Single | 12 | 1.19% | 5/ 12 | 41.67% | 2/ 7 | 28.57% | 1.46 | 0.5680 |
Triple Vessel Disease vs. Single | 6 | 0.60% | 2/ 6 | 33.33% | 2/ 7 | 28.57% | 1.17 | 0.8530 |
Left Main Disease | 4 | 0.40% | 0/ 4 | 0.00% | 86/ 1,001 | 8.59% | 0.00 | 0.5399 |
Preop IABP | 15 | 1.49% | 7/ 15 | 46.67% | 79/ 990 | 7.98% | 5.85 | 0.0000 |
Age 60 - 65 vs. Age < 60 | 148 | 14.73% | 9/ 148 | 6.08% | 16/ 392 | 4.08% | 1.49 | 0.3240 |
Age 66 - 70 vs. Age < 60 | 158 | 15.72% | 17/ 158 | 10.76% | 16/ 392 | 4.08% | 2.64 | 0.0028 |
Age 71 - 80 vs. Age < 60 | 257 | 25.57% | 34/ 257 | 13.23% | 16/ 392 | 4.08% | 3.24 | 0.0000 |
Age > 80 vs. Age < 60 | 50 | 4.98% | 10/ 50 | 20.00% | 16/ 392 | 4.08% | 4.90 | 0.0000 |
E.F. 45% - 54% vs. E.F. >=55% | 202 | 20.10% | 15/ 202 | 7.43% | 31/ 371 | 8.36% | 0.89 | 0.6955 |
E.F. 35% - 44% vs. E.F. >=55% | 106 | 10.55% | 9/ 106 | 8.49% | 31/ 371 | 8.36% | 1.02 | 0.9648 |
E.F. 25% - 34% vs. E.F. >=55% | 55 | 5.47% | 7/ 55 | 12.73% | 31/ 371 | 8.36% | 1.52 | 0.2885 |
E.F.< 25% vs. E.F. >=55% | 14 | 1.39% | 3/ 14 | 21.43% | 31/ 371 | 8.36% | 2.56 | 0.0906 |
E.F. Unknown vs. E.F. >=55% | 257 | 25.57% | 21/ 257 | 8.17% | 31/ 371 | 8.36% | 0.98 | 0.9342 |
LVEDP <15 | 172 | 17.11% | 10/ 172 | 5.81% | 29/ 249 | 11.65% | 0.50 | 0.0420 |
LVEDP >=15 | 249 | 24.78% | 29/ 249 | 11.65% | 10/ 172 | 5.81% | 2.01 | 0.0420 |
PA Sys <30 | 48 | 4.78% | 1/ 48 | 2.08% | 49/ 540 | 9.07% | 0.22 | 0.0960 |
PA Sys >=30 | 540 | 53.73% | 49/ 540 | 9.07% | 1/ 48 | 2.08% | 4.50 | 0.0960 |
PA Diast <15 | 84 | 8.36% | 4/ 84 | 4.76% | 45/ 481 | 9.36% | 0.51 | 0.1680 |
PA Diast >=15 | 481 | 47.86% | 45/ 481 | 9.36% | 4/ 84 | 4.76% | 1.97 | 0.1680 |
PA Wedge <15 | 93 | 9.25% | 4/ 93 | 4.30% | 38/ 435 | 8.74% | 0.49 | 0.1510 |
PA Wedge >=15 | 435 | 43.28% | 38/ 435 | 8.74% | 4/ 93 | 4.30% | 2.03 | 0.1510 |